Literature DB >> 32112736

Systemic treatment of hepatocellular carcinoma: standard of care in China and elsewhere.

Jean-Luc Raoul1, Julien Edeline2.   

Abstract

Entities:  

Year:  2020        PMID： 32112736     DOI： 10.1016/S1470-2045(20)30082-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  17 in total

1.  Preoperative radiomics model using gadobenate dimeglumine-enhanced magnetic resonance imaging for predicting β-catenin mutation in patients with hepatocellular carcinoma: A retrospective study.

Authors:  Fengxia Zeng; Hui Dai; Xu Li; Le Guo; Ningyang Jia; Jun Yang; Danping Huang; Hui Zeng; Weiguo Chen; Ling Zhang; Genggeng Qin
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

2.  Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.

Authors:  Yujing Xin; Yi Yang; Ning Liu; Yi Chen; Yanan Wang; Xinyuan Zhang; Xiao Li; Xiang Zhou
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Identification of the hub gene BUB1B in hepatocellular carcinoma via bioinformatic analysis and in vitro experiments.

Authors:  Jie Fu; Xiao Zhang; Likun Yan; Yaoli Shao; Xinxu Liu; Yuan Chu; Ge Xu; Xundi Xu
Journal:  PeerJ       Date:  2021-02-23       Impact factor: 2.984

4.  Prediction of Microvascular Invasion in Hepatocellular Carcinoma With a Multi-Disciplinary Team-Like Radiomics Fusion Model on Dynamic Contrast-Enhanced Computed Tomography.

Authors:  Wanli Zhang; Ruimeng Yang; Fangrong Liang; Guoshun Liu; Amei Chen; Hongzhen Wu; Shengsheng Lai; Wenshuang Ding; Xinhua Wei; Xin Zhen; Xinqing Jiang
Journal:  Front Oncol       Date:  2021-03-16       Impact factor: 6.244

5.  COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.

Authors:  Zewen Chu; Xin Shi; Gaoyang Chen; Xuejun He; Yayun Qian; Haibo Wang; Li Tao; Yanqing Liu; Wei Jiang; Jue Chen
Journal:  Front Pharmacol       Date:  2021-03-31       Impact factor: 5.810

6.  Protein kinase N1 promotes proliferation and invasion of liver cancer.

Authors:  Xia Wang; Yansong Ge; Mingqi Shi; Hanhan Dai; Wei Liu; Peiyuan Wang
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

7.  Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery.

Authors:  Yu-Fei Zhao; Xiu Xiong; Kai Chen; Wei Tang; Xu Yang; Zheng-Rong Shi
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

8.  KIF14 and KIF23 Promote Cell Proliferation and Chemoresistance in HCC Cells, and Predict Worse Prognosis of Patients with HCC.

Authors:  Chunxia Cheng; Xingxing Wu; Yu Shen; Quanxi Li
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

9.  Long noncoding RNA MACC1-AS1 promotes the stemness of hepatocellular carcinoma cells by antagonizing miR-145.

Authors:  Yuling Guo; Jiuhong Zhong; Fang Wu; Zhengyu Zhan
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

10.  DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway.

Authors:  Xiaoyun Hu; Guosheng Yuan; Qi Li; Jing Huang; Xiao Cheng; Jinzhang Chen
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.